http://pvrinstitute.org/ 2026-03-02T10:59:13+00:00 daily 1.0 http://pvrinstitute.org/learning-hub/events/8th-international-leh-symposium-2026-therapeutic-targets-molecular-mechanisms 2025-10-27T11:34:07+00:00 0.5 http://pvrinstitute.org/learning-hub/events/6th-paediatric-3rd-adult-latam-ph-symposium 2025-10-29T15:20:50+00:00 0.5 http://pvrinstitute.org/learning-hub/events/living-legends-paul-corris-newcastle-university 2026-03-23T10:51:41+00:00 0.5 http://pvrinstitute.org/learning-hub/events/tbx4-syndrome-bench-and-bedside 2026-03-18T15:17:13+00:00 0.5 http://pvrinstitute.org/learning-hub/events/living-legend-marlene-rabinovitch-stanford-university 2026-03-11T10:29:28+00:00 0.5 http://pvrinstitute.org/learning-hub/events/i-brasillinois-symposium-infection-and-pvd 2026-03-25T11:24:45+00:00 0.5 http://pvrinstitute.org/learning-hub/events/pulmonary-hypertension-community-call-april 2026-03-31T12:15:51+01:00 0.5 http://pvrinstitute.org/learning-hub/events/pvri-symposium-genetics-inspired-therapeutics-pulmonary-hypertension-ph 2026-03-23T12:22:03+00:00 0.5 http://pvrinstitute.org/learning-hub/events/pvri-2027-bangkok 2026-04-02T12:01:31+01:00 0.5 http://pvrinstitute.org/learning-hub/events/sex-matters-translational-advances-respiratory-and-pah-research 2026-03-11T11:17:11+00:00 0.5 http://pvrinstitute.org/learning-hub/events/imaging-pulmonary-arterial-hypertension 2026-03-18T15:26:44+00:00 0.5 http://pvrinstitute.org/learning-hub/events/living-legends-werner-seeger-justus-liebig-universitat-giessen 2026-03-25T12:05:33+00:00 0.5 http://pvrinstitute.org/learning-hub/events/epigenetic-strategies-mitigate-acute-altitude-induced-lung-injury 2026-03-25T16:00:21+00:00 0.5 http://pvrinstitute.org/node/3 2026-03-02T10:59:13+00:00 0.5 http://pvrinstitute.org/learning-and-research 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/upcoming-events 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-and-research/latest-news 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/pulmonary-hypertension 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/membership 2025-09-09T08:20:11+01:00 0.5 http://pvrinstitute.org/iddi-workstreams-task-forces 2026-01-12T08:47:42+00:00 0.5 http://pvrinstitute.org/support-us 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/about-us 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/membership/member-directory 2025-12-05T08:28:57+00:00 0.5 http://pvrinstitute.org/learning-hub/material/nt-pro-bnp-predictive-morbidity-and-mortality-after-pulmonary 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/march-2024-pvri-community-call-ke-yuan-yunhye-kim-rebecca-vanderpool-and 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/february-2024-pvri-community-call-katarina-zeder-and-laszlo-farkas 2026-02-24T15:46:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/exploratory-analysis-accuracy-echocardiographic-parameters-assessment-right 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/early-identification-sox17-deficiency-infants-guide-management-heritable 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/predictors-early-mortality-after-lung-transplantation-idiopathic-pulmonary 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/no-genetic-causal-association-between-iron-status-and-pulmonary-artery 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/factors-associated-discontinuation-treatment-pulmonary-arterial-hypertension 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/single-institution-anesthetic-experience-catheterization-pediatric-pulmonary 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/18f-fluorodeoxyglucose-uptake-positron-emission-tomography-patients-ipah-and 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/nf-kb-affected-serum-levels-tnf-and-il-1b-activation-mapknf-kb-signaling 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/reduced-exercise-capacity-occurs-intrinsic-skeletal-muscle-dysfunction 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cardiac-effort-and-6-min-walk-distance-correlate-stroke-volume-measured 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/single-cell-transcriptional-profiling-lung-health-and-pulmonary-arterial 2026-03-17T11:47:51+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-tumor-thrombotic-microangiopathy-due-early-gastric-carcinoma 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ion-channels-pathogenic-role-and-therapeutic-intervention-pulmonary-arterial 2026-03-17T11:47:43+00:00 0.5 http://pvrinstitute.org/learning-hub/material/microbiome-microbial-metabolites-ipvd-microbes-virtual-symposium-series 2026-03-17T11:58:47+00:00 0.5 http://pvrinstitute.org/learning-hub/material/conceptualising-ph-through-global-lens 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-tbx4-neonatal-and-pediatric-developmental-lung-disease 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pvri-presidents-welcome-pvri-2024-congress 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/past-and-next-50-years-ph-pvri-perspective 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-are-goals-pvri-global-health-sessions 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-included-ph 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-do-we-know-and-not-know-about-global-epidemiology-and-burden-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-data-sources-are-available-understand-global-burden-disease-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/multi-omics-approach-pathophenotype-and-precision-therapeutics-pah 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/balloon-pulmonary-angioplasty-under-awake-veno-arterial-extracorporeal 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/africa-regional-differences 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/south-america-regional-differences 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/building-high-value-health-systems-opportunities-and-challenges 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/global-overview-diagnostics 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/management-and-treatment-options-low-and-middle-income-countries 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/platelet-rnas-detection-cancer-and-ph 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/creating-digital-twin-evaluation-and-management-pah 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/gene-networks-controlling-pvd-lessons-alveolar-and-acinar-dysplasia 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/omics-hypothesis-insights-molecular-spatial-phenotyping 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/primer-drug-repositioning-and-repurposing-strategies 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/beyond-clot-cteph-pathobiology 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/liquid-biopsies-during-course-pvd 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/iddi-real-world-evidence-workstream-current-state-future-opportunities-ph 2026-03-17T11:57:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/ipvd-consortium-when-hiv-meets-schistosoma-immune-non-immune-determinants-pv 2026-03-17T11:57:32+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-embolism-cteph-one-disease-different-phenotypes 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/take-deep-breath-inhalational-therapies-group-3-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sglt2-inhibitors-and-emerging-therapies-hfpef-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/activin-signaling-inhibitors-pah 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/building-bridges-shunts-and-devices-support-advanced-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/not-just-little-adults-clinical-update-paediatric-pvd 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ins-and-outs-pdgf-signaling-therapeutic-paradigm 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/adding-flexibility-ph-trials-implementing-adaptive-designs-overview 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/global-assessment-access-care-patients-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/reversal-inflammatory-reprogramming-single-cell-resolution-vasodilator-agents 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/screening-patients-schistosomiasis-associated-hepatosplenic-disease-ph 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/soteria-long-term-follow-study-sotatercept-pah 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/evolving-technology-monitoring-and-measuring-physical-activity-accelerometry 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impahct-randomized-phase-2b3-study-inhaled-imatinib-pulmonary-arterial 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/plasma-nedd9-increased-following-sars-cov-2-infection-and-associates-indices 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-intensification-and-personalization-combination-rx 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-endarterectomy-chronic-thromboembolic-pulmonary-hypertension 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/unlocking-potential-genetic-research-pulmonary-arterial-hypertension-insights 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/enhancing-drug-development-paediatric-pulmonary-hypertension-integrative 2026-03-17T11:47:34+00:00 0.5 http://pvrinstitute.org/learning-hub/material/tobacco-smoking-risk-pulmonary-hypertension 2026-03-17T11:55:25+00:00 0.5 http://pvrinstitute.org/learning-hub/material/will-increase-study-levitate-group-3-ph-awareness-and-interest 2026-03-17T11:56:16+00:00 0.5 http://pvrinstitute.org/learning-hub/material/ph-associated-chronic-lung-disease-constellation-phenotypes 2026-03-17T11:56:10+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-copd-unmet-clinical-need 2026-03-17T11:55:51+00:00 0.5 http://pvrinstitute.org/learning-hub/material/inhaled-treprostinil-pulmonary-hypertension-associated-interstitial-lung 2026-03-17T11:55:16+00:00 0.5 http://pvrinstitute.org/learning-hub/material/safety-inhaled-nitric-oxide-withdrawal-severe-chronic-pulmonary-hypertension 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/evaluating-efficacy-and-safety-oral-triple-sequential-combination-therapy 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/actigraphy-methodology-kids-mod-pah-trial-physical-activity-functional 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/inverse-causal-relationship-between-serum-25-hydroxyvitamin-d-levels-and 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-vascular-pressure-respiratory-swings-copd-and-ild-candidates-lung 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/change-health-related-quality-life-early-follow-patients-pulmonary-arterial 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/simplified-risk-stratification-based-cardiopulmonary-exercise-test-spanish 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/recognition-diagnosis-and-operability-assessment-chronic-thromboembolic 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/beneficial-effects-balloon-pulmonary-angioplasty-patients-chronic 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/understanding-what-drives-genetic-study-participation-perspectives-patients 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/younger-age-initiation-subcutaneous-treprostinil-associated-better-response 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-artery-wave-intensity-analysis-pulmonary-hypertension-associated 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hemodynamic-response-inhaled-nitric-oxide-patients-pulmonary-hypertension-and 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/using-pah-sympact-assess-quality-life-patients-pulmonary-hypertension 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-evaluation-code-based-algorithms-identify-patients-pulmonary 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/structured-evaluation-unclear-dyspnea-attempt-shorten-diagnostic-delay 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/experimental-schistosoma-haematobium-pulmonary-hypertension 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/patients-cteph-and-mild-hemodynamic-severity-disease-improve-similar-level 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-patient-perspectives-toward-pulmonary-rehabilitation 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-body-position-hemodynamic-measurements-during-exercise-tale-two-bikes 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/bmpr2-mutation-and-clinical-response-imatinib-case-heritable-pulmonary 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-setting-interstitial-lung-disease-approach-management 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cs1-controlled-release-formulation-valproic-acid-treatment-patients-pulmonary 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-vascular-dysfunction-without-pulmonary-hypertension-distinct 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exercise-and-pulsatile-pulmonary-vascular-loading-chronic-thromboembolic 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rare-case-scimitar-syndrome-pulmonary-arterial-hypertension-adult-female 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rare-sequelae-esophageal-perforation-fibrosing-mediastinitis 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/safety-and-efficacy-balloon-pulmonary-angioplasty-technically-operable 2025-06-19T11:55:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/january-2024-pvri-community-call-sergio-caravita-claudia-baratto-corey 2025-06-19T11:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/april-2024-pvri-community-call-joseph-newman-and-esther-nossent 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fungi-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:57:10+00:00 0.5 http://pvrinstitute.org/learning-hub/material/viruses-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:57:01+00:00 0.5 http://pvrinstitute.org/learning-hub/material/parasites-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:56:54+00:00 0.5 http://pvrinstitute.org/learning-hub/material/role-tregs-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:56:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/inflamed-lung-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:54:53+00:00 0.5 http://pvrinstitute.org/learning-hub/material/endothelium-ipvd-inflammation-and-infection-virtual-symposium-series 2026-03-17T11:55:03+00:00 0.5 http://pvrinstitute.org/learning-hub/material/direct-prostacyclin-transition-pediatric-patients-pulmonary-hypertension 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/early-bedside-detection-pulmonary-perfusion-defect-electrical-impedance 2025-06-19T11:55:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-local-complement-activation-covid-19-lung-disease 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/covid-19-and-pvd-lessons-learned-hiv-associated-pulmonary-disease 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/high-altitude-and-covid-19-potential-effects-pulmonary-circulation 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-management-ph-patients-during-covid-19-pandemic 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/effect-hiv-pah-role-hiv-nef-and-emap-ii 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-covid-19-right-ventricular-function-and-exercise-tolerance 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/scars-never-felt-wound-post-covid-19-pulmonary-fibrosis-and-pvd 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/immune-landscape-hiv-and-schistosomiasis-co-infection 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hiv-and-schistosomiasis-co-infection 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/regulation-lysosomal-activity-reprograms-lung-endothelial-sterol-metabolism 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fit-phuk-cohort-study-deciphering-rosetta-stone-digital-endpoints 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/stratified-adaptive-trial-designs 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-can-bayesian-adaptive-designs-offer-trials-rare-disease 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/putting-physician-corner-patient-centred-trial 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fda-center-drug-evaluation-research-cder-division-cardiology-nephrology-dcn 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fnih-initiative-further-clinical-outcome-assessment-coa-development-dht 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/taking-plunge-actigraphy-usa-china-lessons-learnt 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-group-2-pathophysiology-pathogenesis-adults 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-group-2-paediatrics 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/panel-discussion-pulmonary-hypertension-group-2 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-group-3-pathophysiology-pathogenesis 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-group-3-adults 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-group-3-paediatrics 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/panel-discussion-pulmonary-hypertension-group-3 2025-06-19T11:55:57+01:00 0.5 http://pvrinstitute.org/learning-hub/material/targeting-histone-deacetylase-hdac-inhibition-pulmonary-hypertension 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/panel-discussion-novel-drug-device-therapies 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mechanism-action-inhaled-therapies-why-do-they-work-how-do-we-design-trials 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/using-large-data-aggregates 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/molecular-clustering 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/imaging-lung 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/panel-discussion-disruptive-technologies-novel-drug-discovery 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/roundtable-practical-solutions-challenges-drug-development 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/chromosome-dynamics-pulmonary-hypertension-mechanism-and-new-treatments 2026-03-17T11:47:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pah-risk-calculators-state-art-assessment 2026-03-17T11:47:13+00:00 0.5 http://pvrinstitute.org/learning-hub/material/controversies-chronic-thromboembolic-pulmonary-hypertension-pro-con-debate 2026-03-17T11:47:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-trials-pulmonary-arterial-hypertension-what-are-we-learning 2026-03-17T11:47:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/nationwide-trends-balloon-pulmonary-angioplasty-and-pulmonary 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/professor-sheila-glennis-haworth-memorial-symposium-paediatric-ph 2026-03-17T11:46:16+00:00 0.5 http://pvrinstitute.org/learning-hub/material/association-between-cancer-and-ph-tale-two-diseases 2026-03-17T11:46:08+00:00 0.5 http://pvrinstitute.org/learning-hub/material/ageing-and-pulmonary-hypertension-endemic-horizon 2026-03-17T11:45:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/bone-marrow-modulation-pulmonary-vascular-disease 2026-03-17T11:45:51+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pro-con-debate-session-2-medical-vs-surgical-or-interventional-therapy-cteph 2026-03-17T11:45:43+00:00 0.5 http://pvrinstitute.org/learning-hub/material/machine-learning-and-artificial-intelligence-approaches-ph-screening-novel 2026-03-17T11:45:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/joint-symposium-ishlt-end-stage-pah-how-and-what-do-we-do-2021 2026-03-17T11:45:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/beyond-dna-unseen-genome-and-novel-omics-approaches-ph 2026-03-17T11:45:19+00:00 0.5 http://pvrinstitute.org/learning-hub/material/notch-receptors-multi-regulators-pah-development 2026-03-17T11:45:12+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pro-con-debate-session-1 2026-03-17T11:45:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/joint-symposium-esc-pulmonary-circulation-heart-failure-syndrome 2026-03-17T11:44:56+00:00 0.5 http://pvrinstitute.org/learning-hub/material/novel-imaging-approaches-pulmonary-hypertension-patients 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/virtual-poster-discussion-session-one 2026-03-17T11:44:49+00:00 0.5 http://pvrinstitute.org/learning-hub/material/connection-between-covid-19-and-pulmonary-vascular-disease 2026-03-17T11:44:42+00:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-lecture-session-2021 2026-03-17T11:44:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/around-globe-global-burden-pulmonary-hypertension 2026-03-17T11:44:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/november-2023-pvri-community-call-adriano-tonelli-dushani-ranasinghe-margaret 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/october-2023-pvri-community-call-sreenath-nayakanti 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/august-2023-pvri-community-call-lucilla-piccari-christoph-knosalla-wolfgang 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/july-2023-pvri-community-call-vinicio-de-jesus-perez-bryan-blette-and-michael 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/june-2023-pvri-community-call-ruisheng-wang-bradley-maron-rachel-walters-lan 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/effects-oxygenation-acute-vasodilator-challenge-pulmonary-arterial 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exploratory-and-confirmatory-factor-analysis-emphasis-10-health-related 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/therapeutic-effects-treat-and-repair-strategy-pediatric-patients-pulmonary 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/left-main-coronary-artery-compression-precapillary-pulmonary-hypertension 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/identifying-consistent-echocardiographic-thresholds-risk-stratification 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/obituary-john-h-newman-md 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/john-newman-md-remembered 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/diagnosis-and-management-chronic-thromboembolic-pulmonary-hypertension-cteph 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/meeting-abstracts-2024-annual-congress-pulmonary-vascular-research-institute 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/april-2023-pvri-community-call-bradley-wertheim 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/march-2023-pvri-community-call-sudarshan-rajagopal-gayathri-viswanathan 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/february-2023-pvri-community-call-jason-zelt 2025-07-24T12:12:55+01:00 0.5 http://pvrinstitute.org/learning-hub/material/january-2023-pvri-community-call-daphne-moutsoglou 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/assessing-quality-life-pulmonary-arterial-hypertension-independent-prognostic 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/bacteria-ipvd-microbes-virtual-symposium-series 2026-03-17T11:58:55+00:00 0.5 http://pvrinstitute.org/learning-hub/material/may-2024-pvri-community-call-eileen-harder-vineet-agrawal-and-fatemeh 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/severe-bronchospasm-and-acute-respiratory-failure-associated-inhaled 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/two-prospective-multicenter-studies-identification-biomarker-signatures-early 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/are-mitochondria-instigator-pulmonary-arterial-hypertension 2026-03-17T11:48:06+00:00 0.5 http://pvrinstitute.org/learning-hub/material/evaluating-technical-use-fitbit-during-intervention-patients-pulmonary 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/association-mildly-elevated-pulmonary-vascular-resistance-major 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cardiopulmonary-exercise-testing-and-2022-definition-pulmonary-hypertension 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/demographic-hemodynamic-characteristics-and-therapeutic-trends-pulmonary 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/excess-healthcare-resource-utilization-and-costs-commercially-insured 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/nonsurgical-treatment-patient-decompensated-right-ventricular-failure-due 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/european-voice-patient-living-pulmonary-hypertension-associated-interstitial 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/perfectly-imperfect-engine-utilizing-digital-twin-paradigm-pulmonary 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/june-2024-pvri-community-call-julien-grynblat-david-montani-and-stravros 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ruptured-pulmonary-arteriovenous-fistula-causing-hemothorax-patient 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-vascular-disease-environmental-pollution-and-climate-change 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/treatment-and-management-chronic-thromboembolic-pulmonary-hypertension-cteph 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/systematic-review-impact-pulmonary-thromboendarterectomy-health-related 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/balloon-pulmonary-angioplasty-chronic-thromboembolic-pulmonary-disease 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/creating-digital-approach-promoting-physical-activity-pediatric-pulmonary 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/human-pulmonary-microvascular-endothelial-cells-respond-damps-injured-renal 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/characteristics-and-risk-profiles-patients-pulmonary-arterial-or-chronic 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/association-risk-assessment-diagnosis-healthcare-resource-utilization-and 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/adult-patient-pulmonary-arterial-hypertension-notch3-mutation-and-leflunomide 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/autoimmune-mechanisms-pulmonary-arterial-hypertension 2026-03-17T11:48:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/quantifying-impact-post-acute-sequelae-coronavirus-cardiopulmonary-endurance 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/we-are-all-together-understanding-organ-crosstalk-pathogenesis-acute 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/integrated-approach-network-pharmacology-molecular-docking-and-clinical 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/early-detection-pulmonary-arterial-hypertension-through-18f-positron-emission 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/selexipag-patients-pulmonary-arterial-hypertension-associated-connective 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/editorial-systematic-review-impact-pulmonary-thromboendarterectomy-health 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-characteristics-and-anticoagulation-patterns-patients-acute 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/immature-reticulocyte-fraction-novel-biomarker-hemodynamic-severity-pulmonary 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/air-travel-patients-suffering-pulmonary-hypertension-prospective-multicentre 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pretransplant-nt-probnp-levels-are-associated-mortality-among-lung-transplant 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/carnitine-consumption-and-effect-oral-supplementation-human-pulmonary 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-selexipag-maintenance-dose-persistence-adherence-and-hospitalization 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/editorial-characteristics-and-risk-profiles-patients-pulmonary-arterial-or 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/novel-evaluation-pulmonary-hypertension-associated-chronic-lung-disease-using 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/inoperable-chronic-thromboembolic-pulmonary-hypertension-evolution-prognosis 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-perfusion-long-term-survivors-covid-19-related-severe-acute 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/better-efficacy-sequential-combination-balloon-pulmonary-angioplasty-after 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-aspects-ipvd-microbes-virtual-symposium-series 2026-03-17T11:59:05+00:00 0.5 http://pvrinstitute.org/learning-hub/material/august-2024-pvri-community-call-steven-d-nathan-alexander-seidinger-and 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/tgf-bmp-signaling-and-mechanism-pulmonary-arterial-hypertension-whats-new 2026-03-17T11:48:21+00:00 0.5 http://pvrinstitute.org/learning-hub/material/use-combined-chemotherapy-and-immunotherapy-improves-pulmonary-arterial 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/balloon-pulmonary-angioplasty-proximal-chronic-thromboembolic-pulmonary 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/tricuspid-annular-plane-systolic-excursion-pulmonary-hypertension-moving 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sex-related-differences-pulmonary-vascular-volume-distribution 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/scoping-review-post-tb-pulmonary-vascular-disease-proceedings-2nd 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/editorial-use-combined-chemotherapy-and-immunotherapy-improves-pulmonary 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/microrna-expression-alteration-chronic-thromboembolic-pulmonary-hypertension 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-general-anesthesia-echocardiographic-assessment-right-ventricular 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/reorganized-subtotal-perfusion-blockade-pulmonary-artery-without-hypertension 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/debunking-myths-about-lung-transplantation-ph-webinar-patients-and-caregivers 2026-03-17T12:06:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-gas-transfer-responses-exercise-training-patients-pulmonary 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/september-2024-pvri-community-call-rubin-tuder-and-athiththan-yogeswaran 2026-02-24T15:47:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hemodynamic-acclimatization-high-altitude-pathophysiological 2026-03-17T12:06:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/copd-associated-pulmonary-hypertension-post-hoc-analysis-perfect-study 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/tricuspid-annular-plane-systolic-excursion-pulmonary-artery-systolic-pressure 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/session-1-young-investigator-symposium 2026-03-17T11:48:29+00:00 0.5 http://pvrinstitute.org/learning-hub/material/nanoparticle-delivery-vegf-and-sdf-1a-approach-treatment-pulmonary-arterial 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/didang-decoction-attenuates-cancer-associated-thrombosis-inhibiting-pad4 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cardiopulmonary-exercise-testing-following-acute-pulmonary-embolism 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ppargetv2-axis-regulates-endothelial-mesenchymal-transition-pulmonary 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ventricular-interdependent-phenotype-mixed-cpc-pulmonary-hypertension-and 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/practices-affecting-macitentan-and-selexipag-patient-persistence-rates 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/influence-nrg1erbb4-signaling-pathway-pulmonary-artery-endothelial-cells 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/prostacyclin-pathway-vasodilators-patients-chronic-thromboembolic-pulmonary 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/barriers-and-facilitators-physical-activity-pediatric-pulmonary-hypertension 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/congruency-between-clinician-assessed-risk-and-calculated-risk-1-year 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/non-invasive-surrogates-right-ventricular-pulmonary-arterial-coupling 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/october-2024-pvri-community-call-eszter-n-toth-and-julien-grynblat 2026-02-24T15:48:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/transcriptome-analyses-reveal-common-immune-system-dysregulation-pah-patients 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/extracorporeal-membrane-oxygenation-ecmo-support-children-pulmonary 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/human-metabolic-responses-high-altitude-hypoxia 2026-03-17T12:05:55+00:00 0.5 http://pvrinstitute.org/learning-hub/material/hemodynamic-markers-independent-pulmonary-capillary-wedge-pressure-can 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/quantitative-pulmonary-perfusion-acute-pulmonary-embolism-and-chronic 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/comorbidity-profiles-and-pulmonary-embolism-risk-assessment-leveraging 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/delta-ligand-4-inhibitor-drug-treatment-induces-pulmonary-hypertension-cancer 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/infection-and-pulmonary-vascular-diseases-consortium-united-against-global 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/session-2-young-investigator-symposium 2026-03-17T11:48:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/bridging-species-divide-limits-rat-models-capturing-human-pvod-mechanisms 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/reply-letter-editor-entitled-bridging-species-divide-limits-rat-models 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/3-year-quality-life-functional-performance-and-long-term-survival-after-acute 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/material/metabolic-and-physiologic-impairments-underlying-long-covid-associated 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/effects-dopamine-b-hydroxylase-inhibition-pressure-overload-induced-right 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/asymmetric-right-ventricular-myocardial-work-correlates-gold-standard 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/november-2024-pvri-community-call-hilary-m-dubrock-and-wusheng-xiao 2026-02-24T15:48:52+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-during-high-dose-gm-csf-therapy-autoimmune-pulmonary 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/high-gestational-leucine-level-dampens-wdpcpmapk-signaling-impair-emt-and 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-vascular-manifestations-hereditary-haemorrhagic-telangiectasia 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/co-infection-ipvd-microbes-virtual-symposium-series 2026-03-17T12:05:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/thbs1-mediates-hypoxia-driven-endmt-pulmonary-hypertension 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/soprano-macitentan-patients-pulmonary-hypertension-following-left-ventricular 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exercise-pulmonary-hypertension-chronic-thromboembolic-pulmonary-disease 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/same-day-discharge-following-outpatient-balloon-pulmonary-angioplasty-single 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/screening-and-diagnosis-pulmonary-hypertension-associated-chronic-lung 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/session-3-young-investigator-symposium 2026-03-17T11:48:49+00:00 0.5 http://pvrinstitute.org/learning-hub/material/synchrotron-based-phase-contrast-micro-ct-combined-histology-decipher 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/right-ventricular-stroke-work-index-pulmonary-arterial-hypertension-and 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-sodium-glucose-co-transporter-2-inhibitors-exercise-induced-pulmonary 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/one-neglected-complication-bpa-process-severe-vagal-response-during 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hepcidin-ferroportin-axis-influences-mitochondrial-function-proliferation-and 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/relationship-between-sexual-function-health-promoting-behaviors-and-quality 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/echocardiographic-grading-right-ventricular-afterload-left-heart-disease 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/7th-international-leh-symposium-lungs-high-altitude-molecular-mechanisms-and 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exploring-genetic-association-between-connective-tissue-diseases-and-risk 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/safety-tolerability-and-efficacy-class-combination-therapy-switch-bosentan 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/performance-risk-stratification-scores-patients-pulmonary-arterial 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/common-variable-immunodeficiency-associated-noninfectious-pulmonary 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/differences-pulmonary-artery-flow-hemodynamics-between-pah-and-ph-hfpef 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/precision-medicine-pulmonary-vascular-disease-future-now-2023-grover 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/new-insights-pediatric-pulmonary-hypertension-bogota-younger-always-better 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/elective-thoracic-surgical-resections-pulmonary-arteriovenous-malformations 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/session-4-young-investigator-symposium 2026-03-17T11:48:57+00:00 0.5 http://pvrinstitute.org/learning-hub/material/disparities-clinical-outcomes-observed-within-electronic-health-record-data 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/comparing-patency-pulmonary-stent-implantation-and-balloon-angioplasty 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/optimizing-medical-pretreatment-balloon-pulmonary-angioplasty-overshoot-or 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/multiscale-three-dimensional-evaluation-and-analysis-murine-lung-vasculature 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/lipid-lowering-drugs-and-pulmonary-vascular-disease-mendelian-randomization 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/petct-imaging-right-heart-perfusion-and-glucose-metabolism-depending-risk 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/adding-new-dimension-ph-imaging 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/right-heart-catheterization-accurately-diagnoses-pulmonary-hypertension 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/wenshen-yiqi-granule-alleviates-chronic-obstructive-pulmonary-disease-long 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/revised-precapillary-pulmonary-hypertension-criteria-and-their-prognostic 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-personal-journey 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/treatment-pathways-finnish-patients-pulmonary-arterial-hypertension-pah-or 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cardiopulmonary-exercise-testing-simultaneous-echocardiography-after 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/heart-rate-variability-pulmonary-arterial-hypertension 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-care-brazil 2026-02-25T14:10:28+00:00 0.5 http://pvrinstitute.org/learning-hub/material/omics-based-data-driven-approaches-early-disease-diagnosis 2026-02-25T14:09:13+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prevalence-ph-sickle-cell-disease-sub-saharan-africa-systematic-review-meta 2026-02-25T14:08:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/cipher-cipher-mri-studies-early-diagnosis-ph 2026-02-25T14:08:02+00:00 0.5 http://pvrinstitute.org/learning-hub/material/advanced-medical-imaging-ai-ph-diagnosis-classification 2026-02-25T14:07:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/cardiopulmonary-exercise-testing-diagnosis-phenotyping-ph-patients 2026-02-25T14:06:33+00:00 0.5 http://pvrinstitute.org/learning-hub/material/classification-diagnosis-paediatric-ph-updates-7th-wsph 2026-02-25T14:05:50+00:00 0.5 http://pvrinstitute.org/learning-hub/material/cteph-cted-approach-early-diagnosis-treatment 2026-02-25T14:05:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/how-pre-clinical-models-can-be-used-improve-clinical-phenotyping-early 2026-02-25T14:04:53+00:00 0.5 http://pvrinstitute.org/learning-hub/material/rv-phenotyping-ph-risk-stratification-treatment 2026-02-25T14:03:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-novel-therapeutics-treatment-algorithm-ph 2026-02-25T14:09:40+00:00 0.5 http://pvrinstitute.org/learning-hub/material/surgical-interventions-mechanical-support-transplant-end-stage-pulmonary 2026-02-25T14:01:18+00:00 0.5 http://pvrinstitute.org/learning-hub/material/risk-stratification-treatment-paediatric-pulmonary-hypertension-ph 2026-02-25T14:00:49+00:00 0.5 http://pvrinstitute.org/learning-hub/material/preclinical-models-support-synergistic-potential-seralutinib-sotatercept 2026-02-25T14:00:22+00:00 0.5 http://pvrinstitute.org/learning-hub/material/medical-surgical-management-cted-cteph 2026-02-25T13:59:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/endotyping-pulmonary-hypertension-ph-copd-possible-role-systematic-lung-iron 2026-02-25T13:58:08+00:00 0.5 http://pvrinstitute.org/learning-hub/material/vasculature-cld-imaging-insights 2026-02-25T13:57:21+00:00 0.5 http://pvrinstitute.org/learning-hub/material/how-do-hfref-hfpef-affect-pulmonary-vasculature-how-can-we-model-it 2026-02-25T14:02:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/congenital-heart-disease-pulmonary-vasculature 2026-02-25T13:54:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-ph-highly-prevalent-rheumatic-heart-disease-sub 2026-02-25T13:54:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/animal-models-heart-disease-pulmonary-hypertension-ph-wolfgang-kubler 2026-02-25T13:53:12+00:00 0.5 http://pvrinstitute.org/learning-hub/material/17b-estradiol-enhances-right-ventricle-angiogenesis-endothelial-cell-fatty 2026-02-25T13:46:31+00:00 0.5 http://pvrinstitute.org/learning-hub/material/effect-pre-and-post-tricuspid-shunts-pulmonary-vasculature 2026-02-25T13:44:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/clinical-aspects-ph-heterogeneity-chronic-lung-disease-same-pah-or-different 2026-02-25T13:53:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/translational-investigations-ph-fibrotic-lung-disease-models 2026-02-25T13:52:00+00:00 0.5 http://pvrinstitute.org/learning-hub/material/rupert-swift-award-lecture-cluster-analysis-identifies-computed-tomography 2026-02-25T13:51:30+00:00 0.5 http://pvrinstitute.org/learning-hub/material/translational-investigations-ph-copd-disease-models 2026-02-25T13:50:57+00:00 0.5 http://pvrinstitute.org/learning-hub/material/elevated-vascular-hyaluronan-therapeutic-target-ph-associated-lung-fibrosis 2026-02-25T13:50:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/how-can-we-study-right-ventricle-develop-novel-therapies 2026-02-25T13:50:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/advances-imaging-rv-function-humans-animal-models-ph 2026-02-25T13:49:37+00:00 0.5 http://pvrinstitute.org/learning-hub/material/cellular-heterogeneity-rv-dysfunction 2026-02-25T13:45:50+00:00 0.5 http://pvrinstitute.org/learning-hub/material/management-right-ventricular-failure-resource-limited-setting 2026-02-25T13:45:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/global-treatment-disparities-within-high-and-middle-high-income-ph-centers 2026-02-25T13:59:34+00:00 0.5 http://pvrinstitute.org/learning-hub/material/approach-treatment-group-i-patients-co-morbidities 2026-02-25T13:58:44+00:00 0.5 http://pvrinstitute.org/learning-hub/material/effects-dapagliflozin-pulmonary-hypertension-ph-rat-pulmonary-vein-banding 2026-02-25T14:02:07+00:00 0.5 http://pvrinstitute.org/learning-hub/material/2025-update-drug-associated-pulmonary-hypertension-ph 2026-02-25T13:42:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/infectious-exposures-pulmonary-vascular-disease 2026-02-25T13:42:09+00:00 0.5 http://pvrinstitute.org/learning-hub/material/high-altitude-exposure-and-ph 2026-02-25T13:41:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/early-life-exposures-and-pulmonary-vascular-disease 2026-02-25T13:41:24+00:00 0.5 http://pvrinstitute.org/learning-hub/material/microbiome-pulmonary-hypertension-ph 2026-02-25T13:40:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/integration-consumer-digital-data-and-ehr-missing-piece-exposome 2026-02-25T13:40:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/exposome-modifiable-factor-pulmonary-hypertension-ph 2026-02-25T13:39:16+00:00 0.5 http://pvrinstitute.org/learning-hub/material/hot-topics-pvri-godeep 2026-02-25T13:38:43+00:00 0.5 http://pvrinstitute.org/learning-hub/material/constructing-framework-disease-modification-pah 2026-02-25T13:38:05+00:00 0.5 http://pvrinstitute.org/learning-hub/material/ct-based-discrimination-cteph-using-deep-learning-clot-vessel-radiomics 2026-02-25T13:37:37+00:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-reported-outcome-measures 2026-02-25T13:36:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/platform-clinical-trials 2026-02-25T13:36:33+00:00 0.5 http://pvrinstitute.org/learning-hub/material/global-perspective-innovative-clinical-trials 2026-02-25T13:36:05+00:00 0.5 http://pvrinstitute.org/learning-hub/material/building-and-testing-personal-digital-twin-pulmonary-hypertension-ph 2026-02-25T13:35:30+00:00 0.5 http://pvrinstitute.org/learning-hub/material/estrogen-and-cyp1b1-regulate-pparg-pulmonary-hypertension-through-ubiquitin 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-ion-channels-pulmonary-hypertension-review 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/phenotypes-and-treatment-strategies-pulmonary-hypertension-interstitial-lung 2026-03-17T12:05:36+00:00 0.5 http://pvrinstitute.org/learning-hub/material/echocardiographic-grading-right-ventricular-afterload-left-heart-disease-0 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/unsupervised-approach-derive-right-ventricular-pressure-volume-loop 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/developing-neonatal-pulmonary-hypertension-core-outcome-set-neoph-cos-study 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rna-seq-and-chip-seq-identification-unique-and-overlapping-target-genes-and 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/introducing-historical-vignettes-pulmonary-circulation 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/perspectives-global-epidemiology-challenges-ipvd-virtual-symposium-series 2026-03-17T12:04:34+00:00 0.5 http://pvrinstitute.org/learning-hub/material/february-2025-pvri-community-call-monica-mukherjee-and-eliza-jheng 2026-02-24T15:50:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/how-most-unlikely-drug-changed-outcome-pulmonary-arterial-hypertension 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/differences-direct-fick-and-thermodilution-measurements-cardiac-output-impact 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/developing-benchmarks-diagnosis-and-treatment-pulmonary-arterial-hypertension 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-embolism-cause-death-lung-transplant-recipients-data-nationwide 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/contribution-qrs-prolongation-transplant-free-survival-sarcoidosis-related 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/flow-cytometric-determination-circulating-progenitor-cells-patients-pulmonary 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/abstract 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/march-2025-pvri-community-call-alexander-rothman-maki-niihori-and-olga 2026-02-24T15:50:38+00:00 0.5 http://pvrinstitute.org/learning-hub/material/high-altitude-may-protect-against-early-development-irreversible-pulmonary 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/heart-rate-variability-marker-disease-severity-pulmonary-arterial 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cellular-communication-network-protein-2-right-ventricle-pulmonary-arterial 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/editorial-elective-thoracic-surgical-resections-pulmonary-arteriovenous 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hank-heart-and-animation-based-education-pulmonary-hypertension 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pediatric-pulmonary-hypertension-associated-increased-circulating-levels-bmp 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/shedding-light-dark-side-moon-understanding-pediatric-right-ventricular-work 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/assessment-relationship-between-six-minute-walk-test-6mwt-serum-chloride 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/resolution-severe-pah-after-late-vsd-closure-8-year-old-clinical-prudence-or 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/importance-age-diagnosis-pulmonary-hypertension-children-living-high-altitude 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/acute-altitude-illnesses-copd-patients-and-healthy-individuals-high-altitude 2026-03-17T12:04:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/editorial-developing-benchmarks-diagnosis-and-treatment-pulmonary-arterial 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/physical-activity-sleep-and-quality-life-pulmonary-arterial-hypertension 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mas1-receptor-activation-necessary-and-sufficient-transduce-ace2-effect-pah 2025-06-19T11:59:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/alterations-ecg-and-right-heart-catheterization-data-pah-patients-who-died 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/prospective-analysis-vasoreactivity-and-mortality-who-group-3-pulmonary 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/diagnostic-accuracy-malnutrition-universal-screening-tool-and-mini 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/societal-costs-associated-pulmonary-arterial-hypertension-subgroups-study 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/prevalence-and-economic-burden-pulmonary-hypertension-and-pulmonary-arterial 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/outcomes-multidisciplinary-care-chronic-thromboembolic-pulmonary-hypertension 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/april-2025-pvri-community-call-lloyd-harvey-stephen-chan-and-aaron-waxman 2026-02-24T15:51:11+00:00 0.5 http://pvrinstitute.org/learning-hub/material/approach-lung-transplantation-pulmonary-arterial-hypertension-delphi 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/transcriptional-signatures-right-ventricle-end-stage-heart-failure 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-new-walk-test-pulmonary-arterial-hypertension-retrospective-cohort-study 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/morbidity-and-mortality-associated-pulmonary-arterial-hypertension 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/subgroup-reanalysis-efficacy-bufei-huoxue-capsules-patients-long-covid-19 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/long-term-treatment-subcutaneous-treprostinil-patients-severe-inoperable 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/heterogeneity-pulmonary-hypertension-nomenclature-empiric-research-studies 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-artery-stent-implantation-fibrosing-mediastinitis-our-clinical 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pvri-international-conference-2025-embracing-heterogeneity 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/activin-regulates-bone-morphogenetic-protein-signaling-pulmonary-endothelial 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-mir-542-3pintegrin-linked-kinasemyocardin-signaling-axis-hypoxic 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/inhibiting-serotonin-synthesis-treatment-pulmonary-arterial-hypertension 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/prognosis-and-treatment-phosphodiesterase-5-inhibitors-combined-post-and 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/endothelial-features-along-pulmonary-vascular-tree-chronic-thromboembolic 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/automated-bi-ventricular-segmentation-and-regional-cardiac-wall-motion 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/arteriovenous-oxygen-content-difference-diagnostic-predictor-preselecting 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/characteristics-daily-walking-bouts-valid-and-reliable-indicators-exercise 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/la-rinconada-expedition-5300-overview-scientific-results 2026-03-17T12:04:10+00:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-perspectives-fixed-dose-combination-therapy-pulmonary-arterial 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/history-adverse-pregnancy-outcomes-women-pulmonary-arterial-hypertension 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/lung-transplant-outcomes-patients-preoperative-catheterization-indicating 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/juvenile-systemic-sclerosis-presenting-severe-pulmonary-vascular-disease-ecmo 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/body-mass-index-and-right-ventricular-structure-insights-observational-and 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ectopic-expansion-pulmonary-vasculature-fibrotic-lung-disease-and-lung 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/prophylactic-effects-radiofrequency-electromagnetic-field-pulmonary-ischemia 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/june-2025-pvri-community-call-breanne-mccarthy-nadine-al-naamani-and-ricardo 2026-02-24T15:51:42+00:00 0.5 http://pvrinstitute.org/learning-hub/material/programmatic-approach-outpatient-cardiac-catheterization-children-stable 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-telehealth-pah-management-benefits-barriers-and-solutions 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-psychological-distress-health-related-quality-life-fatigue-and-pain 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-cardiac-output-methods-classification-pulmonary-hypertension 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/melatonin-improves-quality-life-oxidative-stress-and-cardiovascular-function 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-sotatercept-will-change-treatment-algorithm 2025-09-04T09:53:55+01:00 0.5 http://pvrinstitute.org/learning-hub/material/implications-new-background-therapy-drug-development 2025-09-04T09:53:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-define-or-prove-disease-modification 2025-09-04T09:52:56+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-imaging-establishing-disease-modifying-effects-trial-drug 2025-09-04T09:52:36+01:00 0.5 http://pvrinstitute.org/learning-hub/material/addressing-sex-differences-treatment-decisions-and-drug-development 2025-09-04T09:52:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-include-underrepresented-patients-cardiovascular-clinical-trials 2025-09-04T09:52:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/procon-debate-big-pharmas-responsibility-prioritise-drug-availability-over 2025-09-04T09:51:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-use-imaging-endpoints-reflecting-pulmonary-circulation-rv 2025-09-04T09:51:17+01:00 0.5 http://pvrinstitute.org/learning-hub/material/n-1-trials-and-randomised-withdrawal-studies 2025-09-04T09:50:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/novel-statistical-approaches-bayesian-statistics-use-win-ration 2025-09-04T09:50:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/practical-and-ethical-aspects-around-ole-studies 2025-09-04T09:50:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/climate-impact-drug-development 2025-09-04T09:49:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/elafin-treatment-pulmonary-arterial-hypertension 2025-09-04T09:49:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/inhaled-mosliciguat-novel-approach-address-unmet-needs-pulmonary-hypertension 2025-09-04T09:49:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/seralutinib-novel-rationally-designed-tyrosine-kinase-inhibitor-treatment-ph 2025-09-04T09:48:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-artery-denervation 2025-09-04T09:48:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pediatric-use-inhaled-iloprost 2025-06-26T14:24:22+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exploring-providers-behaviors-attitudes-and-preferences-treatment-pulmonary 2025-06-26T14:30:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/anxiety-and-depression-screening-youth-pediatric-pulmonary-hypertension 2025-06-26T14:36:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hypopituitarism-induced-continuous-infusion-pgi2-analogues-case-series-and 2025-06-26T14:49:01+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exercise-induced-oxygen-desaturation-and-heart-rate-response-during-6-min 2025-06-30T13:54:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-inflammatory-immune-cells-hypoxic-pulmonary-hypertension 2026-03-17T12:08:40+00:00 0.5 http://pvrinstitute.org/learning-hub/material/world-ph-day-2021 2025-07-03T15:04:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/outpatient-intravenous-dobutamine-right-ventricular-support-during-inhaled 2025-07-03T15:53:54+01:00 0.5 http://pvrinstitute.org/learning-hub/material/practical-considerations-managing-patients-tyvaso-dpi-treprostinil-inhalation 2025-07-08T09:25:52+01:00 0.5 http://pvrinstitute.org/learning-hub/material/survival-outcomes-and-impact-targeted-pah-therapy-portopulmonary-hypertension 2025-07-09T13:58:17+01:00 0.5 http://pvrinstitute.org/learning-hub/material/2025-select-abstracts-18th-annual-international-conference-neonatal-and 2025-07-09T14:30:35+01:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-pulmonary-hypertension-carrying-flna-loss-function-variant 2025-07-14T14:42:39+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sex-differences-among-patients-treated-balloon-pulmonary-angioplasty-chronic 2025-07-16T14:02:40+01:00 0.5 http://pvrinstitute.org/learning-hub/material/enhancing-drug-development-paediatric-pulmonary-hypertension-integrative-0 2025-07-16T14:09:04+01:00 0.5 http://pvrinstitute.org/learning-hub/material/randomized-placebo-controlled-trial-peri-operative-treprostinil-pediatric 2025-07-16T14:19:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hemodynamic-patterns-interstitial-lung-disease-snapshot-clinical-practice-and 2025-07-16T14:22:00+01:00 0.5 http://pvrinstitute.org/learning-hub/material/bioinformatics-analysis-identifies-potential-key-gene-pathogenesis-pulmonary 2025-07-17T16:19:52+01:00 0.5 http://pvrinstitute.org/learning-hub/material/risk-assessment-models-and-event-free-survival-pulmonary-arterial 2025-07-18T13:45:24+01:00 0.5 http://pvrinstitute.org/learning-hub/material/melatonin-pulmonary-arterial-hypertension-promising-adjunctive-therapy 2025-07-24T14:51:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/paediatric-bridge-transplant 2026-03-17T12:08:30+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pericardial-effusion-and-prostacyclin-analog-toxicity-after-initiation 2025-08-04T11:09:39+01:00 0.5 http://pvrinstitute.org/learning-hub/material/digital-inclusion-scottish-national-pulmonary-hypertension-population 2025-08-04T11:18:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/important-differences-disease-severity-echocardiography-findings-and-referral 2025-08-04T11:21:34+01:00 0.5 http://pvrinstitute.org/learning-hub/material/reassessment-current-iron-deficiency-definition-pulmonary-hypertension 2025-08-04T11:40:35+01:00 0.5 http://pvrinstitute.org/learning-hub/material/development-novel-pulmonary-endovascular-device-treat-patients-pulmonary 2025-08-04T11:46:45+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pharmacologic-management-segmental-pulmonary-hypertension-children-after 2025-08-04T11:51:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/case-recurrent-pulmonary-tumor-thrombotic-microangiopathy-associated-gastric 2025-08-04T12:01:32+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-pulmonary-vascular-microenvironment-chronic-thromboembolic-pulmonary 2025-08-04T12:03:36+01:00 0.5 http://pvrinstitute.org/learning-hub/material/characterization-population-intermediate-risk-status-pulmonary-arterial 2025-08-04T12:05:40+01:00 0.5 http://pvrinstitute.org/learning-hub/material/my-quest-calcium-channel-blockers-first-medical-treatment-patients-pulmonary 2025-08-05T14:52:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/emergence-oral-sildenafil-pulmonary-hypertension-management 2025-08-05T14:58:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/call-better-poph-risk-assessment-model-and-treatment-direction 2025-08-05T15:03:34+01:00 0.5 http://pvrinstitute.org/learning-hub/material/unraveling-nonenzymatic-nitric-oxide-production-and-its-impact-pulmonary 2025-08-06T11:38:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/effect-regulating-fundc1-mitophagy-mediated-cgassting-pathway-oleic-acid 2025-08-06T11:43:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/my-introduction-pulmonary-hypertension 2025-08-06T11:46:25+01:00 0.5 http://pvrinstitute.org/learning-hub/material/genesis-and-legacy-nhlbi-patient-registry-characterization-primary-pulmonary 2025-08-12T12:00:22+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fda-approval-epoprostenol-treat-primary-pulmonary-hypertension 2025-08-14T12:27:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/predicting-response-switching-phosphodiesterase-type-5-inhibitor-riociguat 2025-08-14T12:33:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/relationship-between-phenotypical-and-echocardiographic-findings-pulmonary 2025-08-18T14:36:44+01:00 0.5 http://pvrinstitute.org/learning-hub/material/significance-pulmonary-vascular-dysfunction-chronic-obstructive-pulmonary 2025-08-19T15:41:07+01:00 0.5 http://pvrinstitute.org/learning-hub/material/global-regional-and-national-burden-pulmonary-arterial-hypertension-among 2025-08-21T16:53:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-shadow-infections-challenges-indian-practice-ipvd 2026-03-17T12:08:22+00:00 0.5 http://pvrinstitute.org/learning-hub/material/renal-outcomes-after-lung-or-combined-heart-lung-transplantation-pulmonary 2025-08-29T10:09:10+01:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-voices-action-understanding-ph-global-survey 2026-03-17T12:08:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/sequential-combination-balloon-pulmonary-angioplasty-distal-lesions-left 2025-09-01T14:20:41+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-vascular-compromise-associated-survival-pediatric-pulmonary 2025-09-02T11:19:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/situ-pulmonary-artery-thrombosis-and-low-flow-stasis-artifact-parenchymal 2025-09-02T12:11:32+01:00 0.5 http://pvrinstitute.org/learning-hub/material/matter-degrees-remarkable-life-mabel-purefoy-fitzgerald-pioneer-hypoxia 2026-03-17T12:08:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/chronic-thromboembolic-pulmonary-hypertension-latvia-epidemiological-insights 2025-09-04T14:32:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-pulmonary-hypertension-characterised-and-treated-children-trisomy-21 2025-09-04T14:34:37+01:00 0.5 http://pvrinstitute.org/learning-hub/material/womens-health-and-pulmonary-vascular-disease 2026-03-17T12:07:47+00:00 0.5 http://pvrinstitute.org/learning-hub/material/case-series-pericardial-effusion-patients-treated-sotatercept 2025-09-10T12:26:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-wean-prostacyclin-infusion-therapy-pulmonary-arterial 2025-09-10T12:30:25+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-new-concepts-and-clinical-use 2026-03-17T11:49:24+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-outcomes-after-closure-atrial-septal-defect-infants 2025-09-15T09:42:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/use-dupilumab-treat-cutaneous-complications-continuous-prostacyclin-infusion 2025-09-15T09:41:44+01:00 0.5 http://pvrinstitute.org/learning-hub/material/september-2025-pvri-community-call-grazyna-kwapiszewska-slaven-crnkovic-and 2026-02-24T15:52:07+00:00 0.5 http://pvrinstitute.org/learning-hub/material/advancing-mortality-prediction-pulmonary-embolism-using-machine-learning 2025-09-23T19:50:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pediatric-pulmonary-hypertension-associated-treatment-myeloproliferative 2025-09-23T19:52:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exploring-influence-metabolic-changes-fibrotic-lung-diseases 2025-09-23T19:57:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/porto-pulmonary-hypertension-children-insights-national-registry 2025-09-26T09:46:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/analysis-clinical-characteristics-54-dead-pregnant-patients-pulmonary-0 2025-10-07T15:12:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exploring-health-related-quality-life-children-pulmonary-hypertension 2025-10-07T15:29:01+01:00 0.5 http://pvrinstitute.org/learning-hub/material/association-estimated-plasma-volume-status-invasive-hemodynamics-and-adverse 2025-10-07T15:32:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/study-design-and-rationale-breathe-easier-tadalafil-therapy-exercise-related 2025-10-07T15:34:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/quantitative-evaluation-lung-perfusion-dynamic-chest-radiography-chronic 2025-10-07T15:38:23+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mir-24-attenuates-oxidative-stress-and-mitochondrial-apoptosis-ventilator 2025-10-08T13:53:13+01:00 0.5 http://pvrinstitute.org/learning-hub/material/living-legend-lewis-rubin-university-california-san-diego 2026-03-17T11:49:32+00:00 0.5 http://pvrinstitute.org/learning-hub/material/real-world-practices-interhospital-transfer-pulmonary-embolism-pulmonary 2025-10-13T16:00:41+01:00 0.5 http://pvrinstitute.org/learning-hub/material/late-onset-pulmonary-arterial-hypertension-associated-features-pulmonary-veno 2025-10-16T09:52:44+01:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-specific-haemodynamic-modeling-estimate-extent-microvascular-disease 2025-10-16T09:59:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/platelet-macrophage-aggregates-remodeled-vessels-patients-pulmonary-arterial 2025-10-16T10:01:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/role-competence-cardiovascular-and-respiratory-nurses-regarding-pulmonary 2025-10-16T10:03:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/drug-development-pulmonary-arterial-hypertension-unleashing-potential-single 2025-10-16T10:05:50+01:00 0.5 http://pvrinstitute.org/learning-hub/material/caveolin-1-central-mediator-acute-lung-injury-animal-model-sickle-cell 2025-10-28T15:23:03+00:00 0.5 http://pvrinstitute.org/learning-hub/material/october-2025-pvri-community-call-clara-hjalmarsson-and-helen-christou 2025-10-24T14:02:54+01:00 0.5 http://pvrinstitute.org/learning-hub/material/operability-guidelines-pvri-4-6-wum2-missing-target 2025-10-28T15:22:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prognostic-role-platelets-pulmonary-arterial-hypertension 2025-10-28T15:25:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/northern-pulmonary-hypertension-personal-experience-and-brief-history 2025-10-28T15:28:36+00:00 0.5 http://pvrinstitute.org/learning-hub/material/early-development-sildenafil-pulmonary-hypertension-retrospective-account 2025-10-28T15:30:44+00:00 0.5 http://pvrinstitute.org/learning-hub/material/high-altitude-induced-pulmonary-hypertension-our-scientific-journey-prove 2025-10-28T15:33:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/high-dose-calcium-channel-blockade-ph-old-lessons-new-tools 2025-10-28T15:35:19+00:00 0.5 http://pvrinstitute.org/learning-hub/material/jugular-venous-catheterization-enhanced-ct-angiography-vivo-3d-visualization 2025-10-28T15:39:37+00:00 0.5 http://pvrinstitute.org/learning-hub/material/joint-perspective-end-life-care-pediatric-pulmonary-hypertension 2025-10-28T15:42:12+00:00 0.5 http://pvrinstitute.org/learning-hub/material/reply-pulmonary-artery-dilatation-different-causes-pulmonary-hypertension 2025-10-28T15:44:44+00:00 0.5 http://pvrinstitute.org/learning-hub/material/how-it-really-happened-development-inhaled-iloprost-pulmonary-arterial 2025-10-28T15:46:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/birth-modern-era-cteph-diagnosis-and-care 2025-10-28T15:47:53+00:00 0.5 http://pvrinstitute.org/learning-hub/material/empiric-pulmonary-arterial-compliance-reflects-resistance-compliance 2025-10-28T15:50:00+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-latin-america 2026-03-17T12:07:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prognostic-value-tapsepasp-ratio-lung-transplant-candidates-advanced 2025-11-03T13:11:18+00:00 0.5 http://pvrinstitute.org/learning-hub/material/predictive-value-quantitative-analysis-spect-vq-imaging-postoperative 2025-11-03T13:12:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/m6a-methylation-modified-hsacirc0044226-attenuates-pulmonary-fibrosis 2025-11-03T13:14:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/iron-and-high-altitude 2026-03-17T12:07:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/incremental-burden-pulmonary-hypertension-among-patients-interstitial-lung 2025-11-07T13:02:08+00:00 0.5 http://pvrinstitute.org/learning-hub/material/identification-and-validation-potential-diagnostic-biomarkers-pulmonary 2025-11-11T15:11:04+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prevalence-pulmonary-arterial-thrombosis-adults-eisenmenger-syndrome 2025-11-11T15:13:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/real-world-comparison-patients-ph-ild-initiating-inhaled-treprostinil-versus 2025-11-11T15:14:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/comparing-pulmonary-arterial-hypertension-care-urban-and-rural-settings 2025-11-11T15:16:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/challenges-developing-novel-therapies-bronchopulmonary-dysplasia-associated 2026-03-17T11:49:40+00:00 0.5 http://pvrinstitute.org/learning-hub/material/phenotypic-analysis-pulmonary-hypertension-associated-low-diffusion-capacity 2025-11-20T14:26:22+00:00 0.5 http://pvrinstitute.org/learning-hub/material/november-2025-pvri-community-call-cole-uhland-and-franz-p-rischard 2026-02-24T15:53:19+00:00 0.5 http://pvrinstitute.org/learning-hub/material/american-lung-association-pulmonary-hypertension-roundtable-executive-summary 2025-11-21T11:48:54+00:00 0.5 http://pvrinstitute.org/learning-hub/material/chronic-dyspnea-and-residual-pulmonary-vascular-sequelae-after-covid-19 2025-11-21T11:52:13+00:00 0.5 http://pvrinstitute.org/learning-hub/material/substance-p-promotes-pulmonary-hypertension-inducing-fibulin-2-methylation 2025-11-27T16:04:56+00:00 0.5 http://pvrinstitute.org/learning-hub/material/macitentan-plus-tadalafil-single-tablet-combination-therapy-chinese-patients 2025-11-27T16:04:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/circulating-pin1-levels-patients-chronic-thromboembolic-pulmonary 2025-11-27T16:04:36+00:00 0.5 http://pvrinstitute.org/learning-hub/material/altered-arginine-metabolism-children-undergoing-fontan-palliation-prospective 2025-11-27T16:04:09+00:00 0.5 http://pvrinstitute.org/learning-hub/material/why-wait-sick-people-get-sicker-paradox-treatment-patients-pulmonary-arterial 2025-11-27T16:03:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/microbesparasites-and-sex-differences-pvds-ipvd-virtual-symposium-series 2026-03-17T12:07:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/initial-experience-multipurpose-mechanical-aspiration-system-acute-high-risk 2025-11-27T16:03:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/progressive-pericardial-effusions-pef-patients-pulmonary-arterial 2025-11-27T16:02:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-arterial-wedge-oxygen-saturation-does-it-confirm-wedge-position 2025-12-05T12:01:58+00:00 0.5 http://pvrinstitute.org/learning-hub/material/systematic-literature-review-exploring-efficacy-and-safety-tadalafil-and 2025-12-05T12:01:47+00:00 0.5 http://pvrinstitute.org/learning-hub/material/exploring-impact-platelet-derived-growth-factor-d-pulmonary-hypertension 2025-12-05T12:01:25+00:00 0.5 http://pvrinstitute.org/learning-hub/material/beyond-resistance-pulmonary-vascular-compromise-mechanistic-window-pediatric 2025-12-05T12:04:26+00:00 0.5 http://pvrinstitute.org/learning-hub/material/identification-diagnostic-biomarkers-causally-associated-gut-microbiota-and 2025-12-05T12:06:53+00:00 0.5 http://pvrinstitute.org/learning-hub/material/improvement-right-ventricular-function-and-pulmonary-pressures-patients 2025-12-05T12:11:11+00:00 0.5 http://pvrinstitute.org/learning-hub/material/transitioning-parenteral-prostanoids-oral-selexipag-pulmonary-arterial 2025-12-11T16:45:36+00:00 0.5 http://pvrinstitute.org/learning-hub/material/lifelong-journey-field-pulmonary-circulation-perspectives-through-lens 2025-12-11T16:47:28+00:00 0.5 http://pvrinstitute.org/learning-hub/material/living-legend-rubin-tuder-university-colorado 2026-03-17T11:49:47+00:00 0.5 http://pvrinstitute.org/learning-hub/material/hipertension-pulmonar-grupo-2-asociada-insuficiencia-cardiaca-y-retencion-de 2026-03-26T11:10:18+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-community-call-december 2026-02-24T15:54:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/rethinking-operability-large-vsd-diastolic-pulmonary-shunt-index-dipsi-and 2025-12-19T09:44:32+00:00 0.5 http://pvrinstitute.org/learning-hub/material/patient-specific-hemodynamic-modeling-clinical-decision-making-chronic 2025-12-19T09:47:24+00:00 0.5 http://pvrinstitute.org/learning-hub/material/burden-prior-authorizations-pediatric-pulmonary-hypertension-medications 2025-12-19T09:49:25+00:00 0.5 http://pvrinstitute.org/learning-hub/material/what-i-learned-study-sex-differences-pulmonary-hypertension-how-following-0 2025-12-19T09:51:18+00:00 0.5 http://pvrinstitute.org/learning-hub/material/real-world-performance-sotatercept-pah-patients-cardiopulmonary-comorbidities 2025-12-19T09:53:06+00:00 0.5 http://pvrinstitute.org/learning-hub/material/assessing-impact-time-diagnosis-and-treatment-patients-pulmonary-arterial 2025-12-19T09:55:06+00:00 0.5 http://pvrinstitute.org/learning-hub/material/discovery-inhaled-prostanoids-pulmonary-hypertension 2025-12-19T09:57:07+00:00 0.5 http://pvrinstitute.org/learning-hub/material/real-world-dosing-and-persistence-oral-treprostinil-initiation-strategies 2025-12-22T15:41:52+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-associated-sickle-cell-disease-and-schistosomiasis 2025-12-22T15:43:48+00:00 0.5 http://pvrinstitute.org/learning-hub/material/leveraging-vascular-over-ventricular-ratios-observational-chronic 2026-01-09T14:10:52+00:00 0.5 http://pvrinstitute.org/learning-hub/material/my-first-step-pulmonary-circulation-world 2026-01-09T14:12:01+00:00 0.5 http://pvrinstitute.org/learning-hub/material/splenectomy-increases-cteph-risk-and-modifies-clinical-features-acute 2026-01-09T14:13:56+00:00 0.5 http://pvrinstitute.org/learning-hub/material/global-resource-disparities-between-pulmonary-hypertension-centers-results 2026-01-09T14:19:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/echinacoside-improves-pulmonary-vascular-remodeling-regulating-l-and-t-type 2026-01-09T14:22:21+00:00 0.5 http://pvrinstitute.org/learning-hub/material/bioengineering-and-bioprinting-advances-ph-research 2026-03-17T11:49:54+00:00 0.5 http://pvrinstitute.org/learning-hub/material/comparison-efficacy-and-safety-sutureless-technique-versus-conventional 2026-01-16T16:28:38+00:00 0.5 http://pvrinstitute.org/learning-hub/material/cerebral-tissue-pulmonary-embolism-masquerading-primary-graft-dysfunction 2026-01-16T16:36:46+00:00 0.5 http://pvrinstitute.org/learning-hub/material/beta-3-adrenoreceptor-agonist-mirabegron-improves-right-ventricular-function 2026-01-16T16:39:18+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prognostic-value-acute-vasoreactivity-chronic-thromboembolic-pulmonary 2026-01-21T09:39:31+00:00 0.5 http://pvrinstitute.org/learning-hub/material/supplemental-oxygen-decreases-cardiac-effort-pulmonary-arterial-hypertension 2026-01-21T09:41:30+00:00 0.5 http://pvrinstitute.org/learning-hub/material/clusters-outcomes-machine-learning-based-phenotyping-intermediate-high-risk 2026-01-21T09:43:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/subcutaneous-treprostinil-ph-associated-left-heart-disease-or-chronic-lung 2026-01-21T09:46:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/effect-early-versus-late-catheter-directed-intervention-clinical-outcomes 2026-01-21T09:48:07+00:00 0.5 http://pvrinstitute.org/learning-hub/material/relationship-pulmonary-artery-aorta-ratio-pulmonary-vascular-resistance 2026-01-21T09:50:06+00:00 0.5 http://pvrinstitute.org/learning-hub/material/methamphetamine-associated-pulmonary-arterial-hypertension-impact-mechanisms 2026-01-21T09:51:33+00:00 0.5 http://pvrinstitute.org/learning-hub/material/refractory-peripheral-pulmonary-stenosis-and-severe-pulmonary-arterial 2026-01-26T14:12:44+00:00 0.5 http://pvrinstitute.org/learning-hub/material/resistin-molecule-beta-participates-calcium-regulation-direct-interaction 2026-01-26T14:14:22+00:00 0.5 http://pvrinstitute.org/learning-hub/material/knowledge-gaps-and-controversies-cardiopulmonary-exercise-testing-assessment 2026-01-26T14:16:17+00:00 0.5 http://pvrinstitute.org/learning-hub/material/beta-alanine-supplementation-ameliorates-right-ventricular-remodeling-caused 2026-01-26T14:17:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/chronic-obstructive-pulmonary-disease-and-pulmonary-hypertension-comparative 2026-01-26T14:19:56+00:00 0.5 http://pvrinstitute.org/learning-hub/material/percutaneous-reperfusion-therapies-vs-anticoagulation-patients-acute 2026-02-04T15:25:24+00:00 0.5 http://pvrinstitute.org/learning-hub/material/transmembrane-protein-100-expression-endothelial-cells-vascularizing-thrombi 2026-02-04T15:28:44+00:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-pulmonary-langerhans-cell-histiocytosis-associated-pulmonary 2026-02-04T15:30:50+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prospective-evaluation-serial-biomarkers-patients-intermediate-high-risk 2026-02-04T15:34:57+00:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-preoperative-hemodynamic-values-development-reperfusion-edema-after 2026-02-04T15:37:31+00:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-clinical-trials-real-world-data-pearls-practice 2026-03-31T12:58:56+01:00 0.5 http://pvrinstitute.org/learning-hub/material/vascular-remodeling-effects-how-else-does-sotatercept-work 2026-03-31T12:58:52+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-impairs-right-ventricular-function-insights-multi-center 2026-03-31T12:58:48+01:00 0.5 http://pvrinstitute.org/learning-hub/material/beyond-sotatercept-what-future-tgfbactivin-signaling-pah 2026-03-31T12:58:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-mitochondrial-metabolic-modulators-ph-opportunities-challenges 2026-03-31T12:58:26+01:00 0.5 http://pvrinstitute.org/learning-hub/material/platelet-activation-macrophage-recruitment-drive-vascular-dysfunction-murine 2026-03-31T12:58:22+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cellular-senescence-ph-divergent-roles-emerging-targets 2026-03-31T12:58:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/evolution-ph-tales-medical-history 2026-03-31T12:58:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/stories-discovery-genetics-pvd 2026-03-31T12:58:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/hamburg-denver-and-sugen-personal-history-how-lung-vascular-research 2026-03-31T12:58:07+01:00 0.5 http://pvrinstitute.org/learning-hub/material/power-we-how-team-building-transformed-pvd-research-giessen-globally 2026-03-31T12:58:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/forgotten-chamber-what-can-we-learn-right-atrium-ph 2026-03-31T12:57:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/misunderstood-chamber-phenotyping-right-ventricle 2026-03-31T12:57:54+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rupert-swift-award-lecture-pro-inflammatory-epicardial-adipose-tissue-key 2026-03-31T12:57:16+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-can-omics-teach-us-about-right-ventricle 2026-03-31T12:57:12+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-can-we-learn-right-ventricle-congenital-heart-disease 2026-03-31T12:57:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-progress-ph-lung-disease-hope-or-hype 2026-03-31T12:57:05+01:00 0.5 http://pvrinstitute.org/learning-hub/material/can-animal-models-ph-copd-deliver-breakthrough 2026-03-31T12:57:01+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-can-bronchopulmonary-dysplasia-ph-teach-us-about-group-3-ph 2026-03-31T12:56:55+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rapid-pro-con-debate-should-we-ever-treat-ph-associated-copd 2026-03-31T12:56:51+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-what-real-global-burden-ph 2026-03-31T12:56:46+01:00 0.5 http://pvrinstitute.org/learning-hub/material/what-can-we-learn-global-ph-registries 2026-03-31T12:56:42+01:00 0.5 http://pvrinstitute.org/learning-hub/material/epidemiological-clinical-burden-pah-latin-america-caribbean-systematic 2026-03-31T12:56:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-bpa-techniques-outcomes-future-directions 2026-03-31T12:55:51+01:00 0.5 http://pvrinstitute.org/learning-hub/material/omics-cteph-are-we-going-see-pathobiology-advances-changing-management 2026-03-31T12:55:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/should-we-be-treat-ctepd-no-ph-multimodal-treatment-era 2026-03-31T12:55:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/rapid-pro-con-debate-era-multimodal-therapy-most-patients-should-have-their 2026-03-31T12:55:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/distinct-rv-vs-lv-macrophage-stress-responses-under-uniform-hypoxia 2026-03-31T12:55:34+01:00 0.5 http://pvrinstitute.org/learning-hub/material/dna-lesions-epigenetics-how-we-can-translate-complex-repair-mechanisms 2026-03-31T12:55:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/carving-new-pathways-translating-pdgfrss-or-sglt2-inhibition-pah-therapy 2026-03-31T12:55:26+01:00 0.5 http://pvrinstitute.org/learning-hub/material/precision-medicine-ph-emerging-promise-molecular-techniques 2026-03-31T12:55:20+01:00 0.5 http://pvrinstitute.org/learning-hub/material/bioinformatic-prediction-therapeutic-targets-ph 2026-03-31T12:55:16+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ai-enhanced-risk-models-ph-survival 2026-03-31T12:55:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sharks-den-pitch-1-integrins-ph-sentinels-disease-or-keys-therapy 2026-03-31T12:54:35+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sharks-den-pitch-3-plasma-proteomics-ph-ready-outperform-bnp-patient 2026-03-31T12:54:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sharks-den-pitch-4-wearables-ph-complement-or-challenger-right-heart 2026-03-31T12:54:26+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-remote-monitoring-pah-it-time 2026-03-31T12:54:23+01:00 0.5 http://pvrinstitute.org/learning-hub/material/beyond-heart-and-lung-inter-organ-cross-talks-ph 2026-03-31T12:54:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/living-ph-life-harmony-research-innovation 2026-03-31T12:54:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/modifying-lifestyle-live-life-full-ph 2026-03-31T12:54:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-next-20-years-ph-what-can-we-expect-our-patients 2026-03-31T12:54:06+01:00 0.5 http://pvrinstitute.org/learning-hub/material/case-igg4-related-disease-developing-during-long-term-high-dose-intravenous 2026-02-12T15:22:59+00:00 0.5 http://pvrinstitute.org/learning-hub/material/echocardiographic-assessment-after-pulmonary-thromboendarterectomy-chronic 2026-02-12T15:24:49+00:00 0.5 http://pvrinstitute.org/learning-hub/material/lin28b-aggravates-inflammation-sepsis-induced-lung-injury-stabilizing-gata6 2026-02-12T15:26:23+00:00 0.5 http://pvrinstitute.org/learning-hub/material/impact-right-heart-catheterization-and-2022-escers-definition-pulmonary 2026-02-12T15:28:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/association-immunoglobulin-e-right-ventricular-dysfunction-pulmonary-arterial 2026-02-12T15:30:02+00:00 0.5 http://pvrinstitute.org/learning-hub/material/iddi-workstream-satellite-meeting-opening-remarks 2026-03-31T12:54:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/therapies-real-world-how-much-do-we-diverge-trial-populations 2026-03-31T12:53:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/data-elements-collected-within-ph-registries-scoping-review 2026-03-31T12:53:23+01:00 0.5 http://pvrinstitute.org/learning-hub/material/fourth-pillar-ph-care-activation-community-linkage-therapeutic-interventions 2026-03-31T12:53:17+01:00 0.5 http://pvrinstitute.org/learning-hub/material/all-should-be-eligible-great-pah-trial-debate 2026-03-31T12:53:13+01:00 0.5 http://pvrinstitute.org/learning-hub/material/iddi-workstream-satellite-meeting-panel-discussion 2026-03-31T12:53:08+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-remap-ild-lessons-remap-pah 2026-03-31T12:53:04+01:00 0.5 http://pvrinstitute.org/learning-hub/material/if-you-had-it-all-designing-ideal-paediatric-ph-clinical-trial 2026-03-31T12:53:00+01:00 0.5 http://pvrinstitute.org/learning-hub/material/assessing-pah-disease-remission-clinical-trial 2026-03-31T12:52:56+01:00 0.5 http://pvrinstitute.org/learning-hub/material/how-assess-disease-remodelling-using-imaging-techniques 2026-03-31T12:52:52+01:00 0.5 http://pvrinstitute.org/learning-hub/material/iddi-workstream-lift-pitch-join-us 2026-03-31T12:52:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/living-legends-stuart-rich-northwestern-university-feinberg-school-medicine 2026-03-17T11:50:02+00:00 0.5 http://pvrinstitute.org/learning-hub/material/withdrawal-study-pah-regulatory-clinical-patient-perspective 2026-03-31T12:52:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/metabolomic-changes-high-altitude 2026-03-31T12:52:04+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ph-children-high-altitude-importance-early-detection-hyperreactivity 2026-03-31T12:51:59+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-arterial-pressure-high-altitude 2026-03-31T12:51:55+01:00 0.5 http://pvrinstitute.org/learning-hub/material/supplemental-oxygen-therapy-relocation-low-altitude-highlanders-risk-ph 2026-03-31T12:51:51+01:00 0.5 http://pvrinstitute.org/learning-hub/material/imaging-task-force-welcome-introduction 2026-03-31T12:51:47+01:00 0.5 http://pvrinstitute.org/learning-hub/material/my-imaging-journey-what-i-currently-get-imaging-what-i-need 2026-03-31T12:51:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ct-imaging-what-features-should-always-be-provided-what-additional-features 2026-03-31T12:51:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/where-ct-imaging-headed 2026-03-31T12:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/material/echocardiography-what-features-should-always-be-provided-what-additional 2026-03-31T12:51:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mr-imaging-what-features-should-always-be-provided-what-additional-features 2026-03-31T12:51:25+01:00 0.5 http://pvrinstitute.org/learning-hub/material/where-mr-imaging-headed-4d-modelling 2026-03-31T12:50:44+01:00 0.5 http://pvrinstitute.org/learning-hub/material/updating-algorithm-imaging-statement 2026-03-31T12:50:38+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ph-latam-update-capri-registry 2026-03-31T12:50:34+01:00 0.5 http://pvrinstitute.org/learning-hub/material/unmet-needs-ph-management-latam 2026-03-31T12:50:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/precision-medicine-pah 2026-03-31T12:50:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/update-diagnosis-treatment-paediatric-ph-latam 2026-03-31T12:50:23+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mexican-guidelines-diagnosis-treatment-ph 2026-03-31T12:50:19+01:00 0.5 http://pvrinstitute.org/learning-hub/material/exercise-testing-diagnosis-treatment-ph-latam 2026-03-31T12:50:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ph-latam-patients-living-usa 2026-03-31T12:50:11+01:00 0.5 http://pvrinstitute.org/learning-hub/material/ph-clinical-trials-latam 2026-03-31T12:50:07+01:00 0.5 http://pvrinstitute.org/learning-hub/material/highlights-nih-sch-pah-multicenter-initiative 2026-03-31T12:49:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/advances-clinical-diagnosis-sch-pah 2026-03-31T12:49:26+01:00 0.5 http://pvrinstitute.org/learning-hub/material/pathways-diagnose-ipvds-rural-areas 2026-03-31T12:49:22+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sleep-infection-ph-triad 2026-03-31T12:49:15+01:00 0.5 http://pvrinstitute.org/learning-hub/material/gut-lung-crosstalk-sch-ph 2026-03-31T12:49:06+01:00 0.5 http://pvrinstitute.org/learning-hub/material/microbiome-treatment-option-pah 2026-03-31T12:49:02+01:00 0.5 http://pvrinstitute.org/learning-hub/material/patients-families-first-outcomes-paediatric-phgps-survey 2026-03-31T12:48:58+01:00 0.5 http://pvrinstitute.org/learning-hub/material/development-new-risk-score-paediatric-ph-collaborative-registry-studies 2026-03-31T12:48:54+01:00 0.5 http://pvrinstitute.org/learning-hub/material/enhancing-paediatric-drug-development-ph-extrapolation-adult-data 2026-03-31T12:48:18+01:00 0.5 http://pvrinstitute.org/learning-hub/material/innovative-imaging-endpoints-paediatric-ph 2026-03-31T12:48:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/navigating-neonatal-landscape-challenges-opportunities-drug-development 2026-03-31T12:48:07+01:00 0.5 http://pvrinstitute.org/learning-hub/material/panama-class-update-results-survey 2026-03-31T12:48:03+01:00 0.5 http://pvrinstitute.org/learning-hub/material/inclusion-paediatric-patients-godeep-registry 2026-03-31T12:47:54+01:00 0.5 http://pvrinstitute.org/learning-hub/material/assessment-operability-shunts-lesions-severe-ph 2026-03-31T12:47:41+01:00 0.5 http://pvrinstitute.org/learning-hub/material/research-ipcs-different-genetic-variants 2026-03-31T12:47:34+01:00 0.5 http://pvrinstitute.org/learning-hub/material/research-critical-care-support-devices-paediatric-ph 2026-03-31T12:47:30+01:00 0.5 http://pvrinstitute.org/learning-hub/material/endothelial-dysfunction-studies-ovine-glenn-model 2026-03-31T12:47:50+01:00 0.5 http://pvrinstitute.org/learning-hub/material/mortality-paediatric-ph 2026-03-31T12:47:26+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cases-columbia-university 2026-03-31T12:46:27+01:00 0.5 http://pvrinstitute.org/learning-hub/material/cases-private-university-hospital-cordoba-argentina 2026-03-31T12:46:22+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-i-25-years-bmpr2-past-present-future-pah-genetics 2026-03-31T12:46:14+01:00 0.5 http://pvrinstitute.org/learning-hub/material/genomic-determinants-therapy-response-pulmonary-veno-occlusive-disease 2026-03-31T12:46:10+01:00 0.5 http://pvrinstitute.org/learning-hub/material/detection-cnvs-through-whole-genome-sequencing-patients-pah 2026-03-31T12:46:06+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-ii-role-mutations-epigenetic-regulator-genes-inflammation-pah 2026-03-31T12:46:00+01:00 0.5 http://pvrinstitute.org/learning-hub/material/transcriptomic-signatures-pulmonary-vascular-remodeling-copdgene 2026-03-31T12:45:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/dna-methylation-signature-pah-potential-molecular-diagnostic-tool 2026-03-31T12:45:48+01:00 0.5 http://pvrinstitute.org/learning-hub/material/sox17-enhancer-variant-reduces-endothelial-progenitor-cells-patients-pah 2026-03-31T12:45:44+01:00 0.5 http://pvrinstitute.org/learning-hub/material/keynote-iii-tbx4life-role-model-global-international-patient-initiative 2026-03-31T12:45:40+01:00 0.5 http://pvrinstitute.org/learning-hub/material/february-2026-pvri-community-call 2026-02-24T15:54:41+00:00 0.5 http://pvrinstitute.org/learning-hub/material/right-ventricular-pressure-volume-loop-analysis-large-animal-research-scoping 2026-02-20T11:01:13+00:00 0.5 http://pvrinstitute.org/learning-hub/material/performance-guideline-recommended-approaches-echocardiographic-investigation 2026-02-20T11:04:03+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-venous-vasculopathy-connective-tissue-disease-associated-pulmonary 2026-02-20T11:07:01+00:00 0.5 http://pvrinstitute.org/learning-hub/material/plasma-gdf-15-and-psp-d-predict-development-pulmonary-arterial-hypertension 2026-02-20T11:08:26+00:00 0.5 http://pvrinstitute.org/learning-hub/material/supraventricular-arrhythmias-pulmonary-hypertension-comprehensive-review 2026-02-26T14:17:22+00:00 0.5 http://pvrinstitute.org/learning-hub/material/efficacy-and-safety-low-dose-prolonged-infusion-thrombolysis-rt-pa-acute 2026-02-26T14:17:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/contrast-reflux-ivc-acute-pulmonary-embolism-predicts-clinical-deterioration 2026-02-26T14:19:33+00:00 0.5 http://pvrinstitute.org/learning-hub/material/prognostic-accuracy-three-dimensional-echocardiography-patients-pre-capillary 2026-03-05T15:49:06+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-global-patient-survey-understanding-invisible-burden 2026-03-05T15:51:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-global-patient-survey-physical-and-psychosocial 2026-03-05T15:54:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-global-patient-survey-groups-2-and-3 2026-03-05T15:56:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/industry-payments-and-prescribing-patterns-pulmonary-hypertension-therapies 2026-03-12T17:15:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/longitudinal-remote-6-minute-walk-distance-and-cardiac-effort-using-wearable 2026-03-12T17:16:54+00:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-decompensated-pulmonary-arterial-hypertension-requiring-va-ecmo 2026-03-12T17:18:45+00:00 0.5 http://pvrinstitute.org/learning-hub/material/sotatercept-patients-eisenmenger-syndrome 2026-03-12T17:20:35+00:00 0.5 http://pvrinstitute.org/learning-hub/material/resting-oxygen-consumption-estimates-scleroderma-can-lead-underestimation 2026-03-12T17:25:20+00:00 0.5 http://pvrinstitute.org/learning-hub/material/time-therapy-activation-and-initial-combination-therapy-titanic-patients 2026-03-12T17:28:05+00:00 0.5 http://pvrinstitute.org/learning-hub/material/advances-understanding-body-composition-ph 2026-03-17T11:50:09+00:00 0.5 http://pvrinstitute.org/learning-hub/material/do-travelers-high-altitude-need-worry-about-their-blood-pressure 2026-03-17T12:26:28+00:00 0.5 http://pvrinstitute.org/learning-hub/material/echocardiography-derived-exercise-pulmonary-hypertension-and-longitudinal 2026-03-19T13:50:15+00:00 0.5 http://pvrinstitute.org/learning-hub/material/physical-activity-traits-wrist-sensors-correlate-clinical-status-pediatric 2026-03-19T13:51:47+00:00 0.5 http://pvrinstitute.org/learning-hub/material/scimitar-syndrome-and-pulmonary-hypertension-pediatric-population 2026-03-19T13:59:13+00:00 0.5 http://pvrinstitute.org/learning-hub/material/early-experience-treprostinil-dry-powdered-inhaler-patients-pulmonary 2026-03-19T14:03:27+00:00 0.5 http://pvrinstitute.org/learning-hub/material/repair-sinus-venosus-atrial-septal-defect-2-patients-severe-pulmonary 2026-03-19T14:05:14+00:00 0.5 http://pvrinstitute.org/learning-hub/material/hemodynamic-driven-staging-heart-failure-preserved-ejection-fraction-using 2026-03-19T14:07:34+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-community-call-march 2026-03-20T10:59:01+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pregnancy-outcomes-following-macitentan-or-bosentan-exposure-or-during 2026-03-25T12:39:34+00:00 0.5 http://pvrinstitute.org/learning-hub/material/pulmonary-hypertension-associated-covid-19-interstitial-lung-disease 2026-03-25T12:41:33+00:00 0.5 http://pvrinstitute.org/learning-hub/material/hipertension-pulmonar-del-grupo-3-asociada-epoc-y-epid 2026-03-26T11:14:32+00:00 0.5 http://pvrinstitute.org/learning-hub/material/comment-echocardiography-derived-exercise-pulmonary-hypertension-and 2026-04-01T16:09:53+01:00 0.5 http://pvrinstitute.org/learning-hub/material/heterogeneity-plasticity-endothelial-dynamics-lung-disease 2026-04-01T16:11:43+01:00 0.5 http://pvrinstitute.org/learning-hub/material/recurrence-pulmonary-hypertension-after-unilateral-lung-transplantation 2026-04-01T16:14:31+01:00 0.5 http://pvrinstitute.org/learning-hub/material/male-sex-associated-severe-pulmonary-hypertension-and-worse-outcome-chronic 2026-04-01T16:16:45+01:00 0.5 http://pvrinstitute.org/learning-hub/news/william-raises-over-ps20k-pvri-250km-seven-day-race-across-desert-memory-his 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/news/celebrating-women-ph-international-womens-day 2025-06-19T11:56:27+01:00 0.5 http://pvrinstitute.org/learning-hub/news/sam-max-harri-toby-and-harrison-race-2024-tough-mudder-pvri 2025-09-02T09:21:38+01:00 0.5 http://pvrinstitute.org/learning-hub/news/tribute-dr-john-newman 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pvris-new-look-same-passion 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/news/british-heart-foundation-funded-position-post-doctoral-research-associate 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/news/dr-anna-hemnes-be-pvri-president-2024-new-advisory-council-established 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-patron-professor-sir-magdi-yacoub-launches-biography 2025-07-24T12:10:56+01:00 0.5 http://pvrinstitute.org/learning-hub/news/fellowship-opportunity-brigham-and-womens-hospital-and-harvard-medical-school 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/news/cereno-scientific-joins-pvri-roundtable-member 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-hub/news/applications-open-phpvd-fellowship-university-pennsylvania 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pha-health-disparities-ph-grant-award 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/news/global-assessment-access-care-patients-pulmonary-hypertension-poster-presentation 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/learning-hub/news/joseph-newman-award-winner-ers-best-abstract-patient-centred-research 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/news/aristotle-classes-ph-achd 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/news/world-heart-day-use-action 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/news/phase-1-pulmonary-hypertension-global-patient-survey-ph-gps-now-closed 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/learning-hub/news/unlocking-insights-potential-ph-gps 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/learning-hub/news/hot-topics-pvri-godeep-pvri-2025 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/news/drug-discovery-and-development-symposium-2025-registration-open 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/news/applications-open-burke-advanced-fellowship-pulmonary-heart-disease-brigham-and 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-2025-lifetime-achievement-award-winner-rubin-tuder 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-2025-rio-embracing-heterogeneity 2025-06-19T11:59:14+01:00 0.5 http://pvrinstitute.org/learning-hub/news/ph-global-patient-survey-becomes-new-pvri-task-force 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-hub/news/iddi-workstreams-your-feedback-needed 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-hub/news/new-leadership-pvris-innovative-drug-discovery-initiative-iddi 2025-07-14T09:48:12+01:00 0.5 http://pvrinstitute.org/learning-hub/news/first-descriptive-findings-phgps-adult-cohort-published-erj-open-research 2025-10-20T13:48:36+01:00 0.5 http://pvrinstitute.org/learning-hub/news/join-our-breath-beyond-borders-fundraising-challenge-november 2025-07-17T09:53:20+01:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-digital-webinar-series-returns-september 2025-07-17T16:42:50+01:00 0.5 http://pvrinstitute.org/learning-hub/news/nominations-now-open-pvri-awards-2026 2025-11-26T15:08:03+00:00 0.5 http://pvrinstitute.org/learning-hub/news/introducing-pvris-patient-engagement-empowerment-series 2026-01-16T16:14:18+00:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-insights-survey 2026-01-26T11:09:28+00:00 0.5 http://pvrinstitute.org/learning-hub/news/2025-26-iddi-workstream-task-forces-report-published 2026-02-16T14:30:05+00:00 0.5 http://pvrinstitute.org/learning-hub/news/brad-maron-begins-term-pvri-president-2026-28 2026-02-16T15:24:55+00:00 0.5 http://pvrinstitute.org/learning-hub/news/pvri-2026-dublin-report 2026-02-27T10:02:44+00:00 0.5 http://pvrinstitute.org/membership/become-member-0 2026-03-24T12:30:34+00:00 0.5 http://pvrinstitute.org/membership/membership-renewal 2025-09-09T14:17:12+01:00 0.5 http://pvrinstitute.org/about-us/what-we-do 2026-03-24T09:39:37+00:00 0.5 http://pvrinstitute.org/about-us/our-people-structure 2026-03-25T11:50:46+00:00 0.5 http://pvrinstitute.org/about-us/pvri-careers-and-opportunities 2026-03-25T11:51:06+00:00 0.5 http://pvrinstitute.org/about-us/our-corporate-partnerships 2026-03-24T10:35:55+00:00 0.5 http://pvrinstitute.org/about-us/contact-us 2026-03-24T09:44:52+00:00 0.5 http://pvrinstitute.org/about-us/strategy-and-governance 2026-03-25T09:06:14+00:00 0.5 http://pvrinstitute.org/pulmonary-hypertension/find-support-locally 2026-03-24T13:47:26+00:00 0.5 http://pvrinstitute.org/pulmonary-hypertension/get-involved-pvri 2025-12-01T17:28:03+00:00 0.5 http://pvrinstitute.org/pulmonary-hypertension/are-you-healthcare-professional 2026-01-14T11:57:59+00:00 0.5 http://pvrinstitute.org/membership/become-member 2026-03-24T12:30:19+00:00 0.5 http://pvrinstitute.org/membership/pvri-grants-sponsorships 2026-01-07T10:45:37+00:00 0.5 http://pvrinstitute.org/membership/pvri-awards 2026-02-05T15:41:35+00:00 0.5 http://pvrinstitute.org/membership/pvri-awards/pvri-achievement-award-nomination-form 2025-12-05T08:28:26+00:00 0.5 http://pvrinstitute.org/membership/our-branding-and-logo 2026-03-24T12:24:01+00:00 0.5 http://pvrinstitute.org/support-us/ways-give 2026-03-24T14:35:09+00:00 0.5 http://pvrinstitute.org/support-us/our-supporter-promise 2025-06-19T11:56:11+01:00 0.5 http://pvrinstitute.org/join-task-force-or-workstream 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/privacy-policy 2026-03-16T12:03:06+00:00 0.5 http://pvrinstitute.org/terms-conditions 2026-03-16T12:03:50+00:00 0.5 http://pvrinstitute.org/diversity-equity-and-inclusion-policy 2026-03-16T12:02:42+00:00 0.5 http://pvrinstitute.org/ethical-sponsorship-fundraising-partnership-policy 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/learning-and-research/pulmonary-hypertension-global-patient-survey-phgps 2026-03-10T14:28:47+00:00 0.5 http://pvrinstitute.org/accessibility-statement 2026-03-16T12:01:01+00:00 0.5 http://pvrinstitute.org/support-us/where-your-money-goes 2026-03-24T14:32:17+00:00 0.5 http://pvrinstitute.org/complaints-policy 2026-03-24T14:20:04+00:00 0.5 http://pvrinstitute.org/pulmonary-hypertension/what-pulmonary-hypertension-ph 2026-01-14T11:43:14+00:00 0.5 http://pvrinstitute.org/learning-and-research/pulmonary-circulation 2026-04-02T11:56:39+01:00 0.5 http://pvrinstitute.org/support-us/become-friend-pvri 2025-06-19T11:58:29+01:00 0.5 http://pvrinstitute.org/digital-clinic-pregnancy-case-study 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/learning-and-research/godeep-global-ph-registry 2025-12-09T15:03:02+00:00 0.5 http://pvrinstitute.org/not-found 2025-06-19T11:56:37+01:00 0.5 http://pvrinstitute.org/nomination-form-pvri-president 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/pvri2025rio/member 2025-06-19T11:58:12+01:00 0.5 http://pvrinstitute.org/vienna-drinks-reception-registration 2025-06-19T11:58:20+01:00 0.5 http://pvrinstitute.org/ddds-2025-member-registration-page 2025-06-19T11:58:42+01:00 0.5 http://pvrinstitute.org/pvri-code-conduct 2026-03-16T12:01:31+00:00 0.5 http://pvrinstitute.org/pvri-2025-rio-hotel-reservation-form 2025-06-19T11:58:49+01:00 0.5 http://pvrinstitute.org/pvri-digital-2025-26-webinar-proposal-form 2025-06-19T11:59:05+01:00 0.5 http://pvrinstitute.org/social-media-policy 2026-03-16T12:03:28+00:00 0.5 http://pvrinstitute.org/digital-clinic-sclerosis-case-study 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/pulmonary-hypertension-digital-clinic 2025-06-20T10:19:58+01:00 0.5 http://pvrinstitute.org/digital-clinic-knowledge-base 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/digital-clinic-bmpr2-case-study 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/your-feedback-needed-our-work-groups-and-subject-areas 2025-06-19T11:51:33+01:00 0.5 http://pvrinstitute.org/learning-and-research/pvri-digital-webinar-series 2026-03-25T12:07:06+00:00 0.5 http://pvrinstitute.org/pulmonary-hypertension/how-empower-yourself-others 2025-12-05T10:39:02+00:00 0.5 http://pvrinstitute.org/cookies-policy 2026-03-16T12:02:19+00:00 0.5 http://pvrinstitute.org/pvri-2026-sponsors-exhibitors 2025-10-31T02:48:14+00:00 0.5 http://pvrinstitute.org/pvri-2026-gala-dinner-awards-presentation-evening 2026-01-19T12:47:39+00:00 0.5 http://pvrinstitute.org/pvri-2026-dublin-member-registration-page 2025-07-16T16:33:31+01:00 0.5 http://pvrinstitute.org/learning-and-research/pulmonary-circulation-gateway-programme/mentee-expression-interest-form 2026-02-25T14:19:33+00:00 0.5 http://pvrinstitute.org/learning-and-research/pulmonary-circulation-gateway-programme 2026-02-25T14:20:37+00:00 0.5 http://pvrinstitute.org/learning-and-research/pulmonary-circulation-gateway-programme/your-role-mentee 2026-02-25T14:20:57+00:00 0.5 http://pvrinstitute.org/genetics-inspired-therapeutics-ph-member-discount-code 2026-03-05T14:24:35+00:00 0.5 http://pvrinstitute.org/ipvd 2026-04-01T15:31:31+01:00 0.5 http://pvrinstitute.org/ipvd/publications-and-events 2026-04-01T15:31:53+01:00 0.5 http://pvrinstitute.org/ipvd/our-story 2026-03-19T12:33:24+00:00 0.5 http://pvrinstitute.org/our-commitment-responsible-use-artificial-intelligence-ai 2026-03-24T16:05:28+00:00 0.5